Concentric Analgesics

Concentric Analgesics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies. The company’s proprietary portfolio of TRPV1 agonist prodrugs is designed to provide long-lasting, selective pain relief following a single local administration. Concentric has three active programs targeting multiple indications with significant unmet needs: post-surgical pain, osteoarthritis, and chronic intractable pain.